Last reviewed · How we verify

NCT03360825

Electrophysiological Comparison of mAP and mADM Using EMG

Completed Last updated 7 March 2019
What this trial tests

trial testing TetraGraph in Surgery in 56 participants. Completed in 20 March 2018.

Timeline
20 November 2017
Primary endpoint
20 March 2018
20 March 2018

Quick facts

Lead sponsorMayo Clinic
StatusCompleted
Study typeOBSERVATIONAL
Enrollment56
Start date20 November 2017
Primary completion20 March 2018
Estimated completion20 March 2018
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Mayo Clinic

Who can join

18 and older, any sex, with Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary aim of this clinical investigation is to examine a prototype of a quantitative monitoring instrument that will meet most, if not all, of the clinical requirements.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of TetraGraph

Trials testing the same drug.

Other recruiting trials for Surgery

Currently open trials in the same condition.

Other Mayo Clinic trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03360825.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing